Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹201 Cr
up ₹11.2 Cr vs Apr 2019
- Stocks held
- 22
- unchanged
- Top 10 weight
- 64.8%
- of the portfolio in its ten largest
- Cash & debt
- 4.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 4
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In May 2019 it disclosed 22 stocks worth ₹201 Cr, up ₹11.2 Cr from Apr 2019. Its largest positions were Sun Pharmaceutical Industries Limited (13.4%), IPCA Laboratories Limited (10.0%), Dr. Reddy's Laboratories Limited (9.5%); the ten largest together made up 64.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 70.2% of its equity. Cash and debt stood at 4.5%. Compared with Apr 2019 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
67%
Holds more cash than 67% of peers
What these mean: concentration · cash
Holdings in May 2019
Download CSVEvery line the fund disclosed, with the change against Apr 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.43% | down 0.48 pts | ₹27 Cr | up ₹60 L | Added |
| IPCA Laboratories Limited | 9.95% | up 0.33 pts | ₹20 Cr | up ₹1.7 Cr | Added |
| Dr. Reddy's Laboratories Limited | 9.52% | down 0.57 pts | ₹19.2 Cr | down ₹1 L | Held |
| Divi's Laboratories Limited | 6.70% | up 1.60 pts | ₹13.5 Cr | up ₹3.8 Cr | Added |
| Indoco Remedies Limited | 4.97% | up 0.16 pts | ₹10 Cr | up ₹86 L | Added |
| Apollo Hospitals Enterprise Limited | 4.96% | up 0.11 pts | ₹10 Cr | up ₹77 L | Added |
| JB Chemicals & Pharmaceuticals Limited | 4.63% | up 0.54 pts | ₹9.3 Cr | up ₹1.6 Cr | Added |
| Cash, TREPS & receivables | 4.54% | down 1.99 pts | ₹9.1 Cr | down ₹3.3 Cr | Trimmed |
| Unichem Laboratories Limited | 4.31% | up 0.28 pts | ₹8.7 Cr | up ₹1 Cr | Added |
| Alembic Pharmaceuticals Limited | 3.24% | up 0.17 pts | ₹6.5 Cr | up ₹68 L | Added |
| Abiomed Inc | 3.06% | up 0.23 pts | ₹6.2 Cr | up ₹78 L | Added |
| Aarti Drugs Limited | 3.01% | up 0.02 pts | ₹6.1 Cr | up ₹38 L | Added |
| Alkem Laboratories Limited | 3.00% | down 0.04 pts | ₹6 Cr | up ₹26 L | Added |
| Ajanta Pharma Limited | 2.99% | up 0.09 pts | ₹6 Cr | up ₹51 L | Added |
| Procter & Gamble Health Limited | 2.96% | up 0.11 pts | ₹6 Cr | up ₹54 L | Added |
| Syngene International Limited | 2.80% | up 0.28 pts | ₹5.6 Cr | up ₹85 L | Added |
| Abbott Laboratories | 2.68% | down 0.23 pts | ₹5.4 Cr | down ₹13 L | Trimmed |
| Jubilant Pharmova Limited | 2.60% | down 0.38 pts | ₹5.2 Cr | down ₹43 L | Trimmed |
| Torrent Pharmaceuticals Limited | 2.55% | down 0.01 pts | ₹5.1 Cr | up ₹26 L | Added |
| Abbott India Limited | 2.46% | down 0.03 pts | ₹4.9 Cr | up ₹23 L | Added |
| Max India Limited | 2.18% | down 0.15 pts | ₹4.4 Cr | down ₹3 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.17% | up 0.03 pts | ₹4.4 Cr | up ₹31 L | Added |
| Dr. Lal Path Labs Limited | 1.27% | down 0.08 pts | ₹2.5 Cr | down ₹2 L | Trimmed |
What changed, Apr 2019 to May 2019
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Divi's Laboratories Limitedup ₹3.8 Cr (+1.60% pts)
- IPCA Laboratories Limitedup ₹1.7 Cr (+0.33% pts)
- JB Chemicals & Pharmaceuticals Limitedup ₹1.6 Cr (+0.54% pts)
- Unichem Laboratories Limitedup ₹1 Cr (+0.28% pts)
- Indoco Remedies Limited ₹86 L (+0.16% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2019, the weight rose most in Healthcare Services (+0.1 pts).
- Healthcare Services14.8% → 14.9%+0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2019 | Apr 2019 | May 2019 |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.7% | 70.3% | 70.2% |
| Healthcare Services | 14.6% | 14.8% | 14.9% |
| Pharmaceuticals | 10.4% | 12.6% | 12.5% |
| Insurance | 2.4% | 2.3% | 2.3% |
Allocation in May 2019change vs Apr 2019
- Pharmaceuticals & Biotechnology (13)70.2%▼ 0.1 pts
- Healthcare Services (5)14.9%▲ 0.1 pts
- Pharmaceuticals (3)12.5%
- Insurance (1)2.3%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, May 2019
4.5%
▼ 2.0 pts vs Apr 2019
- Cash alone
- 4.6%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 4.5% – 28.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.